Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging -: Relation to clinical characteristics in subgroups of patients with multiple sclerosis

被引:104
作者
van Walderveen, MAA
Lycklama à Nijeholt, GJ
Adèr, HJ
Jongen, PJH
Polman, CH
Castelijns, JA
Barkhof, F
机构
[1] Free Univ Amsterdam Hosp, Magnet Resonance Ctr Multiple Sclerosis Res, NL-1007 MB Amsterdam, Netherlands
[2] Free Univ Amsterdam Hosp, Dept Radiol, NL-1007 MB Amsterdam, Netherlands
[3] Free Univ Amsterdam Hosp, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[4] Free Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam, Netherlands
[5] Stichting Multiple Sclerose Ctr, Nijmegen, Netherlands
关键词
D O I
10.1001/archneur.58.1.76
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Context: Hypointense lesions on T1-weighted spin-echo magnetic resonance images (T1 lesions) represent destructive multiple sclerosis (MS) lesions, consisting of axonal loss and matrix destruction. These lesions are being used as a secondary outcome measure in phase III clinical trials. Clinical determinants of T1 lesions may differ between subgroups of patients with MS and subsequently may have implications for the selection of patients for clinical trials. Objective: To determine if clinical characteristics of patients with MS are related to T1 lesion volume. Design: A survey of 138 patients with MS (52 with relapsing-remitting MS, 44 with secondary progressive MS, and 42 with primary progressive MS). Setting: The Magnetic Resonance Center for Multiple Sclerosis Research, University Hospital "Vrije Universiteit," Amsterdam, the Netherlands. Main Outcome Measures: Type of MS, Expanded Disability) Status Scale (EDSS) score, sex, age at first symptoms, and T1 lesion volume. Results: Patients with secondary progressive MS have the highest T1 lesion volume, patients with relapsing-remitting MS have a lower T1/T2 ratio than patients with secondary progressive MS and patients with primary progressive MS. In patients with relapsing-remitting MS and secondary progressive MS, T1 lesion volume relates to disease duration and EDSS score, while in patients with primary progressive MS sex is important. A trend toward higher T1 lesion volume was shown for male patients with primary progressive MS when compared with female patients with primary progressive MS (1.0 cm(3) vs 0.3 cm(3), P=.03); a trend toward higher T1 lesion volume was found with age at onset in patients with relapsing-remitting MS and in patients with primary progressive MS. Conclusions: In patients with MS different clinical characteristics associate with T1 lesion volume, suggesting a more destructive type of lesions in certain subgroups. A possible sex difference in (destructive) lesion development on magnetic resonance imaging should be evaluated in more detail, preferably in a cohort.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 45 条
[11]   Prognostic factors for survival in multiple sclerosis [J].
Levic, ZM ;
Dujmovic, I ;
Pekmezovic, T ;
Jarebinski, M ;
Marinkovic, J ;
Stojsavljevic, N ;
Drulovic, J .
MULTIPLE SCLEROSIS JOURNAL, 1999, 5 (03) :171-178
[12]  
Losseff N A, 1996, Mult Scler, V1, P218
[13]   Progressive cerebral atrophy in multiple sclerosis - A serial MRI study [J].
Losseff, NA ;
Wang, L ;
Lai, HM ;
Yoo, DS ;
GawneCain, ML ;
McDonald, WI ;
Miller, DH ;
Thompson, AJ .
BRAIN, 1996, 119 :2009-2019
[14]   Defining the clinical course of multiple sclerosis: Results of an international survey [J].
Lublin, FD ;
Reingold, SC .
NEUROLOGY, 1996, 46 (04) :907-911
[15]   THE NATURAL-HISTORY OF MULTIPLE-SCLEROSIS - A REGIONAL STUDY WITH SOME LONGITUDINAL DATA [J].
MILLER, DH ;
HORNABROOK, RW ;
PURDIE, G .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (05) :341-346
[16]   Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis [J].
Miller, DH ;
Albert, PS ;
Barkhof, F ;
Francis, G ;
Frank, JA ;
Hodgkinson, S ;
Lublin, FD ;
Paty, DW ;
Reingold, SC ;
Simon, J .
ANNALS OF NEUROLOGY, 1996, 39 (01) :6-16
[17]   Brain and spinal cord abnormalities in multiple sclerosis - Correlation between MRI parameters, clinical subtypes and symptoms [J].
Nijeholt, GJLA ;
van Walderveen, MAA ;
Castelijns, JA ;
van Waesberghe, JHTM ;
Polman, C ;
Scheltens, P ;
Rosier, PFWM ;
Jongen, PJH ;
Barkhof, F .
BRAIN, 1998, 121 :687-697
[18]  
O'Riordan JI, 1998, MULT SCLER J, V4, P408, DOI 10.1177/135245859800400502
[19]   SURVIVAL PATTERN AND CAUSE OF DEATH IN PATIENTS WITH MULTIPLE-SCLEROSIS - RESULTS FROM AN EPIDEMIOLOGIC SURVEY IN NORTH-EAST SCOTLAND [J].
PHADKE, JG .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (05) :523-531
[20]   CLINICAL ASPECTS OF MULTIPLE-SCLEROSIS IN NORTH-EAST SCOTLAND WITH PARTICULAR REFERENCE TO ITS COURSE AND PROGNOSIS [J].
PHADKE, JG .
BRAIN, 1990, 113 :1597-1628